Abstract
Acute kidney injury (AKI) is a frequent complication in decompensated liver disease, contributing to the unacceptably high morbidity and mortality of these patients. Currently, serum creatinine is the biomarker of choice for the diagnosis and classification of AKI, however, it is influenced by a number of factors that make its use inaccurate and late, both in diagnosis and prognosis. Ther…